2017 Annual Meeting

International Society of Gynecological Pathologists

March 5 2017, 1:30pm to 5:00pm

Description

International Society of Gynecological Pathologists

The International Society of Gynecological Pathologist (ISGyP) Endometrial Carcinoma Project: Areas of Controversy

Sunday, March 5, 2017
1:30 PM 5:00 PM
CC 225

Session Credits: 3 CME and SAMs

Moderators: W. Glenn McCluggage, MD, FRCPath, Belfast Health and Social Care Trust, Belfast, Ireland
Vinita Parkash, MBBS, Yale University School of Medicine, New Haven, CT

Course Description:
The Board of International Society of Gynecological Pathologists convened a project to recommend guidelines for standardizing the diagnosis and reporting of endometrial carcinoma in 2015. The project was undertaken because of discussions that occurred while updating the most recent edition of the WHO blue book on the Diagnosis of Gynecologic Neoplasms. Experts felt that there were significant inconsistencies in terminology and criteria for the diagnosis of endometrial carcinoma around the world. It was also felt that there was need to update the currently used criteria to include recent advances in the understanding of molecular events in endometrial carcinoma. The ISGyP sponsored a broad project which included conducting a survey of the membership of the ISGyP to identify areas of controversy and confusion in the diagnosis of endometrial carcinoma. A conference was subsequently convened in Seattle in 2016, where discussion occurred and where possible guidelines were vetted and standardized criteria proposed. This conference will discuss the culmination of those efforts and will present those guidelines and recommendations, which will be published in 2017 in the International Journal of Gynecological Pathology.

Upon completion of this symposium, participants should be better able to:

  • Define the most useful histological features and immunohistochemical stains to diagnose clear cell carcinoma of the endometrium
  • Identify the patterns of mixed endometrial cancer and distinguish them from diagnostic mimics.
  • Describe strategies for classifying high grade endometrial carcinoma into clinically relevant categories
  • Determine how to assess staging parameters in endometrial carcinoma
  • Describe the standardized grossing of tissues removed for the diagnosis and staging of endometrial carcinoma
  • Describe the recent developments in the molecular classification of endometrial carcinoma

Agenda

1:30 PM

Rationale and Background for the ISGyP Endometrial Carcinoma Project
Vinita Parkash, MBBS, Yale University School of Medicine, New Haven, CT

1:40 PM

The Diagnosis of Mixed Carcinoma of the Endometrium
Joseph Rabban, MD, MPH, University of California San Francisco, San Francisco, CA

2:05 PM

Strategies for Classifying Endometrial Carcinoma with Clear Cells
Oluwole Fadare, MD, University of California San Diego, San Diego, CA

2:35 PM

Strategies for Typing High Grade Endometrial Carcinoma
Blake Gilks, MD, Vancouver General Hospital, Vancouver, BC

3:05 PM

Break

3:30 PM

ISGyP Award Ceremony
W. Glenn McCluggage, FRCPath, Belfast Health and Social Care Trust, Belfast, Ireland

3:35 PM

Selected Areas of Difficulty in the Staging of Endometrial Carcinoma
W. Glenn McCluggage, FRCPath, Belfast Health and Social Care Trust, Belfast, Ireland

4:05 PM

Optimal Grossing Parameters in the Reporting of Endometrial Cancers
Anais Malpica, MD, MD Anderson Cancer Center, Houston, TX

4:30 PM

Audience Q & A and Comments

Meetings

home-circle-inset-1
view more